We have proved that FOXM1 level is associated with poor prognosis in early-stage cervical cancer patients in our previous studies [3], so we deduced that miR-216b may also be related to prognosis of cervical cancer patients. This evidence concerns the gene FOXM1 and cervical carcinoma.